Reaction
Degenerative Bone Disease reporting signals
As of the last recalculation, Degenerative Bone Disease appears in 437 FAERS reports alongside 10 co-occurring drug terms. The strongest observed disproportionality signal is ELVITEGRAVIR, COBICISTAT, EMTRICITABINE, AND TENOFOVIR DISOPROXIL FUMARATE (PRR 158.2).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Elvitegravir, Cobicistat, Emtricitabine, And Tenofovir Disoproxil Fumarate | 28 | 158.2 | 158.7 |
| Elvitegravir, Cobicistat, Emtricitabine, And Tenofovir Alafenamide | 30 | 152.4 | 152.9 |
| Emtricitabine And Tenofovir Alafenamide | 26 | 116.1 | 116.3 |
| Bictegravir Sodium, Emtricitabine, And Tenofovir Alafenamide Fumarate | 38 | 109.3 | 109.5 |
| Efavirenz | 18 | 80.2 | 80.3 |
| Emtricitabine And Tenofovir Disoproxil Fumarate | 65 | 79.6 | 79.7 |
| Tenofovir Disoproxil Fumarate | 44 | 70.4 | 70.5 |
| Tapentadol Hydrochloride | 19 | 28.2 | 28.2 |
| Asfotase Alfa | 5 | 24.0 | 24.0 |
| Dolutegravir Sodium | 4 | 21.3 | 21.3 |